dostęp otwarty
HPV-pozytywny rak jamy ustnej - etiologia i czynniki ryzyka.
- Zakład Chirurgii Stomatologicznej Gdańskiego Uniwersytetu Medycznego, ul. Dębinki 7, 80-211 Gdańsk, Polska
- Zakład Patologii i Neuropatologii Gdańskiego Uniwersytetu Medycznego, ul. Dębinki 1, 80-211 Gdańsk, Polska
- Zakład Medycyny Molekularnej, Katedra Biochemii Klinicznej Gdańskiego Uniwersytetu Medycznego, ul. Dębinki 7, 80-211 Gdańsk, Polska
- Wojewódzki Szpital Specjalistyczny w Olsztynie, ul. Żołnierska 18, 10-561 Olsztyn, Polska
dostęp otwarty
Streszczenie
Streszczenie
Słowa kluczowe
HPV; OSCC; rak płaskonabłonkowy jamy ustnej
Tytuł
HPV-pozytywny rak jamy ustnej - etiologia i czynniki ryzyka.
Czasopismo
Numer
Strony
102-106
Opublikowany online
2018-07-13
Wyświetlenia strony
3809
Wyświetlenia/pobrania artykułu
15952
Rekord bibliograficzny
Forum Medycyny Rodzinnej 2018;12(3):102-106.
Słowa kluczowe
HPV
OSCC
rak płaskonabłonkowy jamy ustnej
Autorzy
Anna Starzyńska
Karolina Ragin
Jacek Gulczyński
Monika Sakowicz-Burkiewicz
Aleksandra Sejda
- Whelan SL, Ferlay J. Cancer Incidence in Five Continents. Age-specific and standardized incidence rates. IARC Sci Publ. 1992(120): 178–861.
- Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92(9): 709–720.
- Herrero R, Castellsagué X, Franceschi S. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003; 95(23): 1772–1783.
- D’Souza G, Agrawal Y, Halpern J, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009; 199(1): 1263–1269.
- Gillison ML, Broutian T, Pickard RKL, et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA. 2012; 307(7): 693–703.
- D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19): 1944–1956.
- Hariri S, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007; 297(8): 813–819.
- Baig S, Siddiqui A, Nayeem A, et al. Human papilloma virus--role in precancerous and cancerous oral lesions of tobacco chewers. J Pak Med Assoc. 2013; 63(10): 1295–1298.
- Dürst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983; 80(12): 3812–3815.
- Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009; 392(1): 1–10.
- Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009; 140(2): 228–234.
- Syrjänen S. Human papillomavirus infections and oral tumors. Med Microbiol Immunol. 2003; 192(3): 123–128.
- Goon PKC, Stanley MA, Ebmeyer J, et al. HPV & head and neck cancer: a descriptive update. Head Neck Oncol. 2009; 1: 36.
- Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14(2): 467–475.
- Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998; 90(21): 1626–1636.
- Kreimer AR, Villa A, Nyitray AG, et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev. 2011; 20(1): 172–182.
- Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4): 244–265.
- van Houten VM, Snijders PJ, van den Brekel MW, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001; 93(2): 232–235.
- Ragin CC, Reshmi SC, Gollin SM. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer. 2004; 110(5): 701–709.
- Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 2009; 35(3): 210–220.
- Klozar J, Kratochvil V, Salakova M, et al. HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol. 2008; 265(Suppl 1): S75–S82.
- Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival. Int J Cancer. 2000; 89(3): 300–304, doi: 10.1002/1097-0215(20000520)89:3<300::aid-ijc14>3.0.co;2-g.
- Iyer NG, Dogan S, Palmer F, et al. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer. Ann Surg Oncol. 2015; 22(13): 4411–4421.
- Dahlgren L, Dahlstrand HM, Lindquist D, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004; 112(6): 1015–1019.
- Näsman A, Nordfors C, Holzhauser S, et al. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma? Eur J Cancer. 2015; 51(1): 55–61.
- D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19): 1944–1956.
- Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100(6): 407–420.